What we do

Regenerating and Reconnecting the Brain

ExQor has developed a unique regenerative biologic.

The regenerative biologic induces the formation of new neurons.

ExQor's regenerative biologic also causes vital connections to form between the new neurons.

ExQor's regenerative biologic does not deal with root causes of a neurodegenerative disorder; rather, it treats its adverse consequences, and thereby restores brain to normal functioning.

Treatments for multiple CNS indications are therefore possible using ExQor's regenerative biologic.

With successful preclinical studies behind it, ExQor is preparing for its first IND application to the FDA for treating cognitive impairments that are consequences of Alzheimer’s disease.

ExQor applications to FDA for treating additional indications with its regenerative biologic will follow.

MRI Detection of Alzheimer's


ExQor also has diagnostic agent development programs using gadolinium and SPIONs (superparamagnetic iron oxide nanoparticles) that would enable conventional MRI systems to have similar molecular resolution to PET, which is not available in most clinics.

The first molecular level MRI application would be detecting and assessing very early-stage Alzheimer's or identifying mild cognitive impairment (MCI) that could convert to Alzheimer's.

Concurrent use of ExQor's regenerative biologic at early MRI detection could treat and mitigate further progression of the disease.

A Strong AI Background


ExQor's founders' also have extensive software experience in developing AI systems for high performance computer systems.

ExQor accordingly will be developing machine learning systems for treating neurodegenerative disorders, which could enable precision dosing, improved maintenance and patient compliance, and more personalized treatments with ExQor's regenerative biologic.

ExQor also could apply its AI knowhow to its molecular level MRI diagnostic agents for improved and/or preventive Alzheimer's treatments via ExQor's regenerative biologic.

ExQor has multiple allowed patents and patents pending.


© 2024 ExQor Technologies, Inc . All rights reserved